Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study (Q46218402)

20 December 2017

title

Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study (English)

1 reference

20 December 2017

1 reference

1

1 reference

20 December 2017

David Colquhoun

2

object named as

D Colquhoun

1 reference

20 December 2017

LIPID Study Investigators

10

object named as

LIPID Study Investigators

1 reference

20 December 2017

Andrew Tonkin

8

object named as

A M Tonkin

1 reference

20 December 2017

author name string

A Keech

3

1 reference

20 December 2017

J Yallop

4

1 reference

20 December 2017

E H Barnes

5

1 reference

20 December 2017

C Pollicino

6

1 reference

20 December 2017

J Simes

7

1 reference

20 December 2017

P Nestel

9

1 reference

20 December 2017

language of work or name

English

0 references

publication date

9 December 2008

1 reference

20 December 2017

International Journal of Obesity

published in

1 reference

20 December 2017

volume

33

1 reference

20 December 2017

issue

1

1 reference

20 December 2017

page(s)

123-130

1 reference

20 December 2017

Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity

cites work

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

Inhibition of leptin release by atrial natriuretic peptide (ANP) in human adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

The effects of imidazoline agents on the aggregation of human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

Leptin: a review of its peripheral actions and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Central actions of adipocyte hormones

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Does leptin cause vascular disease?

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin, obesity and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin induces vascular smooth muscle cell hypertrophy through angiotensin II- and endothelin-1-dependent mechanisms and mediates stretch-induced hypertrophy

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin is associated with increased risk of myocardial infarction.

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Adiponectin and protection against type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Obesity, adiponectin and vascular inflammatory disease

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Plasma adiponectin levels and risk of myocardial infarction in men.

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Adiponectin and Coronary Heart Disease: The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Serum leptin and myocardial infarction in hypertension

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Plasma leptin and prognosis in patients with established coronary atherosclerosis.

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Association of insulin resistance, hyperleptinemia, and impaired nitric oxide release with in-stent restenosis in patients undergoing coronary stenting

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin, but not adiponectin, predicts stroke in males

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

High leptin levels are associated with stroke

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin and cardiovascular disease: response to therapeutic interventions

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin, from fat to inflammation: old questions and new insights.

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

https://api.crossref.org/works/10.1038/IJO.2008.224

1 reference

7 January 2021

Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Unraveling the multiple roles of leptin in inflammation and autoimmunity

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Independent association between plasma leptin and C-reactive protein in healthy humans

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

The effect of pegylated recombinant human leptin (PEG-OB) on weight loss and inflammatory status in obese subjects

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C.

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob/ob) mice

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Atorvastatin reduces serum leptin concentration in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Leptin receptor polymorphism is associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men.

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Association of hypoadiponectinemia with coronary artery disease in men

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Plasma adiponectin levels and five-year survival after first-ever ischemic stroke

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox

1 reference

https://api.crossref.org/works/10.1038/IJO.2008.224

7 January 2021

Identifiers

DOI

10.1038/IJO.2008.224

1 reference

20 December 2017

1 reference

20 December 2017